MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
MESOBLAST LTD
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026
$11.95−1.33 (-10.02%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Mesoblast from other investors
No posts about MESO yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.